InvestorsHub Logo
Followers 80
Posts 24703
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Wednesday, 11/08/2017 9:18:58 AM

Wednesday, November 08, 2017 9:18:58 AM

Post# of 27622
BPMX - .2089 Pre-market now at .25/.26

BioPharmX Receives Concurrence from FDA on Phase 3 Acne Study Plans

BZ: UPDATE: BioPharmX Announces FDA Offered Positive Feedback Related To Design Of Co.'s Planned Phase 3 Trial For BPX-01



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.